Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and etomidate requirements for loss of consciousness in older patients
ChiCTR2000032347Phase 4Recruiting
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and etomidate (3 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Requirement of propofol or etomidate for disappearance of eyelash reflex during induction. Started May 2020; status: recruiting.
02
Drugs
propofoletomidate
Beyond the preview
Go deeper on ChiCTR2000032347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032347.